
GeneTAG Technology Inc Profile last edited on: 1/22/2020
CAGE: 47UK2
UEI: N78BHV2RJKJ8
Business Identifier: Precise, simple and inexpensive Molecular Detection Systems Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
3781 Presidential Parkway Suite 9
Atlanta, GA 30340
Atlanta, GA 30340
(678) 805-8840 |
info@genetagtech.com |
www.genetagtech.com |
Location: Single
Congr. District: 04
County: DeKalb
Congr. District: 04
County: DeKalb
Public Profile
GeneTAG offers seven different DNA Detection Switch (DDS) probe systems specialized for high-fidelity detection (error-checking probes) or for low-cost detection (generic-component probes). Employing two interacting components: a fluorescent labeled probe and a nearly complementary quencher-labeled antiprobe, probes preferentially bind to their intended targets, liberating fluorescence. Specificity is enhanced by providing an excess of antiprobes that intercept any incorrect hybridizations between probes and off-targets, thereby preventing false positives. Error-checking DDS probes: Conventional dual-labeled qPCR probes lack error-checking mechanisms and cannot provide multi-temperature single base discrimination. The firms error-checking DDS probes function either as internal probes (iDDS or Flip probes) or primer-probes (ZIPR probes), wherein each target-specific probe is combined with a slightly mismatched, competitive antiprobe. The antiprobe blocks off-target detection over a wide range of annealing temperatures (up to 30°C), and facilitates multiplexing. The internal probes provide reliable single base discrimination and are also useful for validating next generation sequencing results. ZIPR primer-probes are stringent reference probes that enable 1- or 2-color detection of targets of interest, such as gene fusions occurring in cancer. Primer-probes label all amplicons for maximum signaling. The firms internal Flip probe system generates linear amplification curves, which are useful for quantitative real-time or endpoint detection. G-Force probes: these are single-molecule G-Force probes employing guanine-mediated fluorescence quenching by forming a hairpin between adjacent C-rich and G-rich sequences. G-Force probes can also serve as reliable reference probes to provide positive amplicon detection in cases where a second probe is distinguishing a specific mutation, and together, the mutant frequency can be assessed.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
5-9Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2022 | 1 | NIH | $258,109 | |
Project Title: Developing a multiplex diagnostic test for SNPs related to dry eye disease | ||||
2021 | 1 | NIH | $253,385 | |
Project Title: Detecting drug-resistant HBV and HCV variants using a DDS probe array | ||||
2020 | 1 | NIH | $242,610 | |
Project Title: Super-Sensitive Detection of Universal Markers of Allograft Rejection | ||||
2019 | 1 | NIH | $242,611 | |
Project Title: Super-Sensitive Detection of BCR-ABL Mutants Driving CML Recurrence | ||||
2019 | 1 | NIH | $225,000 | |
Project Title: Detecting species-specific bacterial meningitis markers with iDDS probes |
Key People / Management
David A Shafer -- President
Peixu Hu -- Chief Financial Officer
James L Murray -- Senior Research Director
Peixu Hu -- Chief Financial Officer
James L Murray -- Senior Research Director
Company News
There are no news available.